Intercept Pharma (ICPT) Tops Q3 EPS by 42c, Revenues Miss; Offers FY18 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. COHR
3. CBRS
4. WYFI
5. EAT
6. SPY
7. GO
8. STUB
9. NVDA
10. ANDG

Go back to Intercept Pharma (ICPT) Tops Q3 EPS by 42c, Revenues Miss; Offers FY18 Revenue Guidance

Intercept Pharmaceuticals (ICPT) PT Lowered to $114 at RBC Capital

November 1, 2018 6:43 AM EDT

RBC Capital analyst Brian Abrahams lowered the price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $114.00 (from $117.00) while maintaining a Sector Perform rating.

Abrahams said overall it was an in-line quarter for PBC sales that met consensus expectations, and some signals of increasing... More